| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |